BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2022
View Archived Issues
Hyaluronidase-expressing oncolytic virus VCN-11 shows promise as cancer immunotherapeutic
Read More
STK-002 confers a dose-dependent increase in OPA1 expression in ADOA retina
Read More
Lhotse Bio discovers lysophosphatidic acid receptor 1 antagonists
Read More
New STING agonists identified at Tyligand Bioscience
Read More
New RET inhibitors synthesized at Shanghai LiteDD
Read More
Suzhou Zelgen Biosciences patents G12C mutant GTPase KRAS inhibitors
Read More
New non-receptor tyrosine-protein kinase TYK2 inhibitors described by PharmaBlock Sciences
Read More
Multiple aging hallmarks show up as epigenetic changes
Read More
Novel zebrafish model of Opa1-mutated dominant optic atrophy
Read More
Intrathalamic administration of AVB.PGRN rescues pathology in Grn-null FTD mice
Read More
AstraZeneca selects IPF target under drug discovery collaboration with BenevolentAI
Read More
EDIT-202 iPSC-derived NK cell therapy shows tumor killing in vivo
Read More
Osivax collaborates with NIAID to combine OVX-836 with NIAID influenza vaccine candidates
Read More
Sosei Heptares and Kallyope collaborate to identify gastrointestinal GPCR targets
Sosei and Kallyope have entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases.
Read More
Nanocapsules efficiently deliver single CRISPR-Cas9 across the blood-brain barrier
Read More